Camlin Fine Sciences Limited (NSE:CAMLINFINE)
India · Delayed Price · Currency is INR 78.95
+0.42 (0.53%)
Nov 11, 2026, 1:39 PM IST
Camlin Fine Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 15,181 | 18,623 | 31,552 | 14,946 | 20,006 | 21,899 | |
Market Cap Growth | -58.75% | -40.98% | 111.10% | -25.29% | -8.65% | 22.86% |
Enterprise Value | 20,969 | 23,447 | 38,070 | 20,852 | 26,685 | 27,042 |
Last Close Price | 78.53 | 96.93 | 167.75 | 87.19 | 124.51 | 136.23 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | 67.41 | - | - | 34.66 | 33.70 |
PS Ratio | 0.80 | 1.08 | 1.94 | 1.03 | 1.19 | 1.55 |
PB Ratio | 1.62 | 1.86 | 3.61 | 1.74 | 2.43 | 2.86 |
P/TBV Ratio | 2.12 | 2.32 | 3.71 | 1.84 | 2.63 | 3.22 |
P/FCF Ratio | 312.79 | 76.00 | - | 19.06 | - | - |
P/OCF Ratio | 26.73 | 22.69 | 137.21 | 10.75 | 39.31 | 15.06 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.11 | 1.36 | 2.34 | 1.43 | 1.59 | 1.92 |
EV/EBITDA Ratio | 31.85 | 25.85 | 18.52 | 10.68 | 12.88 | 18.58 |
EV/EBIT Ratio | - | 62.97 | 24.43 | 16.37 | 17.43 | 27.86 |
EV/FCF Ratio | 432.68 | 95.69 | - | 26.60 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.74 | 0.72 | 0.75 | 0.80 | 0.97 | 0.85 |
Debt / EBITDA Ratio | 10.98 | 6.83 | 3.01 | 3.34 | 3.72 | 4.24 |
Debt / FCF Ratio | 142.55 | 29.39 | - | 8.71 | - | - |
Net Debt / Equity Ratio | 0.67 | 0.61 | 0.58 | 0.70 | 0.86 | 0.68 |
Net Debt / EBITDA Ratio | 12.93 | 6.74 | 2.48 | 3.09 | 3.41 | 3.56 |
Net Debt / FCF Ratio | 128.33 | 24.96 | -26.20 | 7.69 | -7.57 | -7.58 |
Asset Turnover | 0.87 | 0.79 | 0.82 | 0.73 | 0.87 | 0.86 |
Inventory Turnover | 1.96 | 1.86 | 1.64 | 1.48 | 1.80 | 2.27 |
Quick Ratio | 0.40 | 0.55 | 0.56 | 0.50 | 0.50 | 0.73 |
Current Ratio | 1.16 | 1.27 | 1.40 | 1.37 | 1.37 | 1.50 |
Return on Equity (ROE) | -9.64% | -3.36% | 7.52% | 6.30% | 5.01% | 8.17% |
Return on Assets (ROA) | -0.26% | 1.07% | 4.90% | 3.97% | 4.96% | 3.70% |
Return on Invested Capital (ROIC) | -0.56% | 2.48% | 10.96% | 7.70% | 5.39% | 5.14% |
Return on Capital Employed (ROCE) | -0.70% | 2.80% | 13.20% | 10.40% | 12.10% | 8.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -0.50% | 1.48% | -4.41% | -6.21% | 2.60% | 2.77% |
FCF Yield | 0.32% | 1.32% | -0.62% | 5.25% | -4.67% | -3.12% |
Payout Ratio | - | - | - | - | 26.58% | - |
Buyback Yield / Dilution | -5.58% | -10.90% | -1.04% | -1.11% | -18.16% | -3.67% |
Total Shareholder Return | -5.58% | -10.90% | -1.04% | -1.11% | -18.16% | -3.67% |